Prospective Analysis of Confocal Laser Endomicroscopy for Assessment of the Resection Bed for Bladder Tumor

Autor: Ben-Max de Ruiter, Jan E. Freund, C. Dilara Savci-Heijink, Jons W. van Hattum, Marinka J. Remmelink, Theo M. de Reijke, Joyce Baard, Guido M. Kamphuis, D. Martijn de Bruin, Jorg R. Oddens

Publikováno v: European Urology Open Science, Vol 71, Iss , Pp 57-62 (2025)

Background and objective: Urothelial bladder cancer (UCB) care requires frequent follow-up cystoscopy and surgery. Confocal laser endomicroscopy (CLE), a probe-based optical technique for real-time microscopic evaluation, has shown promising accuracy

Externí odkaz: https://doaj.org/article/a7de06285c5044bf8f82db309c187cb9

Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer

Autor: de Ruiter, Ben-Max, van Hattum, Jons W., Lipman, Djoeri, de Reijke, Theo M., van Moorselaar, R. Jeroen A., van Gennep, Erik J., Maartje Piet, A.H., Donker, Mila, van der Hulle, Tom, Voortman, Jens, Oddens, Jorg R., Hulshof, Maarten C.C.M., Bins, Adriaan D.

Publikováno v: In European Urology November 2022 82(5):518-526

A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice

Autor: de Ruiter, Ben-Max, van de Kamp, Maaike W., van Steenbergen, Jonah P.Z., Franckena, Martine, Boormans, Joost L., de Feijter, Jeantine M., Bins, Adriaan D., Hulshof, Maarten C.C.M., de Reijke, Theo M., Schaake, Eva, Oddens, Jorg R.

Publikováno v: In European Urology Open Science May 2022 39:7-13

The Effect of Metformin on Bladder Cancer Incidence and Outcomes

Autor: Jons W. van Hattum, Ben Max de Ruiter, Jorg R. Oddens, Theo M. de Reijke, Johanna W. Wilmink, Remco J. Molenaar

Publikováno v: van Hattum, J W, de Ruiter, B M, Oddens, J R, de Reijke, T M, Wilmink, J W & Molenaar, R J 2022, ' The Effect of Metformin on Bladder Cancer Incidence and Outcomes : A Systematic Review and Meta-Analysis ', Bladder Cancer, vol. 8, no. 2, pp. 211-228 . https://doi.org/10.3233/BLC-211653

BACKGROUND: Effective oral treatment options for urothelial bladder cancer (BC) are lacking. Metformin, the most frequently used oral drug in type II diabetes mellitus, has putative anticancer properties and could, therefore, influence BC incidence a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::759fc1a286b85d5328f3bfe9ab94f4d5
https://doi.org/10.3233/blc-211653

Bladder-sparing chemoradiotherapy combined with immune checkpoint inhibition for locally advanced urothelial bladder cancer—a review

Autor: Jons W. van Hattum, Ben-Max de Ruiter, Jorg R. Oddens, Maarten C. C. M. Hulshof, Theo M. de Reijke, Adriaan D. Bins

Publikováno v: Cancers, Vol 14, Iss 38, p 38 (2022)
Cancers
van Hattum, J W, de Ruiter, B-M, Oddens, J R, Hulshof, M C C M, de Reijke, T M & Bins, A D 2022, ' Bladder-sparing chemoradiotherapy combined with immune checkpoint inhibition for locally advanced urothelial bladder cancer—a review ', Cancers, vol. 14, no. 1, 38 . https://doi.org/10.3390/cancers14010038

Simple Summary Immunotherapy with immune checkpoint inhibition (ICI) has provided durable treatment responses in advanced, metastatic, bladder cancer patients. The first trials using checkpoint inhibitors before surgery, when the cancer is still conf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8d18fa321bb9f741fab374cd7adb998
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85121442230&origin=inward